StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) income statement

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30240% above fair value
$143.37−1.09 (-0.75%)

Close on Nov 17, 2026Market cap $353.72BP/E 114.7Yield 2.29%

Merck & Co., Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
73.0%
Operating margin
–
Net margin
4.8%
Return on equity, FY2025
36.9%

Financial strength

Current ratio
1.32
Debt to equity
1.29
Debt to assets
41.5%
Cash to current liabilities
24.7%

Valuation

P/E ratio
114.7
Price to sales
5.31
Price to book
8.44
Dividend yield
2.29%

See a number that looks wrong?